Methylprednisolone pulse therapy: An alternative management of severe COVID-19

Patricia Merab Sauñe1, Mayte Bryce-Alberti2, Arianna Sibila Portmann-Baracco2

  • 1Facultad de Medicina, Universidad Privada San Juan Bautista, José Antonio Ave, 302-304, Chorrillos District, Lima, Peru.

Insights

Severe COVID-19 cases managed at home with methylprednisolone (MP) pulse therapy showed favorable outcomes. This treatment effectively resolved symptoms, highlighting MP

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pharmacology

Background:

  • COVID-19 presents with varying severity, from asymptomatic to severe respiratory disease.
  • Severe COVID-19 progression is linked to a "cytokine storm," an excessive inflammatory response.
  • Glucocorticoids (GC) modulate inflammation; high-dose pulse therapy can induce immune cell apoptosis.

Observation:

  • Two severe COVID-19 cases, initially denied medical care, were managed at home.
  • Treatment involved three-day methylprednisolone (MP) pulse therapy.
  • Patients experienced favorable symptom evolution and resolution.

Findings:

  • Home-based methylprednisolone pulse therapy demonstrated efficacy in severe COVID-19.
  • This approach led to significant clinical improvement and symptom resolution.
  • Findings suggest MP pulse therapy can mitigate the inflammatory cascade in severe COVID-19.

Implications:

  • Timely GC administration, particularly MP pulse therapy, may prevent Acute Respiratory Distress Syndrome (ARDS).
  • This treatment strategy offers a potential alternative for managing severe COVID-19, especially when institutional care is limited.
  • Further research into GC pulse therapy for COVID-19-induced cytokine storms is warranted.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
601
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
94
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
160
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
632
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.3K